Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor

PURPOSE: Low dose metronomic (LDM) chemotherapy, combined with VEGF signaling pathway inhibitors, is a highly effective strategy to coordinately inhibit angiogenesis and tumor growth in many adult preclinical cancer models. We have tested the efficacies of daily oral LDM topotecan alone and in combi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kumar, Sushil, Mokhtari, Reza Bayat, Sheikh, Reihaneh, Wu, Bing, Zhang, Libo, Xu, Ping, Man, Shan, Oliveira, Indhira Dias, Yeger, Herman, Kerbel, Robert S., Baruchel, Sylvain
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687796/
https://ncbi.nlm.nih.gov/pubmed/21788355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0078
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados